Literature DB >> 29997283

Brushed nasal epithelial cells are a surrogate for bronchial epithelial CFTR studies.

John J Brewington1,2, Erin T Filbrandt1, F J LaRosa1, Jessica D Moncivaiz1, Alicia J Ostmann1, Lauren M Strecker1, John P Clancy1,2.   

Abstract

Recent advances in the management of cystic fibrosis (CF) target underlying defects in the CF transmembrane conductance regulator (CFTR) protein, but efficacy analyses remain limited to specific genotype-based subgroups. Patient-derived model systems may therefore aid in expanding access to these drugs. Brushed human nasal epithelial cells (HNEs) are an attractive tissue source, but it remains unclear how faithfully they recapitulate human bronchial epithelial cell (HBE) CFTR activity. We examined this gap using paired, brushed HNE/HBE samples from pediatric CF subjects with a wide variety of CFTR mutations cultured at the air-liquid interface. Growth and structural characteristics for the two cell types were similar, including differentiation into mature respiratory epithelia. In electrophysiologic analysis, no correlation was identified between nasal and bronchial cultures in baseline resistance or epithelial sodium channel (ENaC) activity. Conversely, robust correlation was demonstrated between nasal and bronchial cultures in both stimulated and inhibited CFTR activity. There was close correlation in modulator-induced change in CFTR activity, and CFTR activity in both cell types correlated with in vivo sweat chloride measurements. These data confirm that brushed HNE cell cultures recapitulate the functional CFTR characteristics of HBEs with fidelity and are therefore an appropriate noninvasive HBE surrogate for individualized CFTR analysis.

Entities:  

Keywords:  Epithelial transport of ions and water; Ion channels; Monogenic diseases; Pulmonology

Mesh:

Substances:

Year:  2018        PMID: 29997283      PMCID: PMC6124537          DOI: 10.1172/jci.insight.99385

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  46 in total

1.  Polarized cultures of human airway epithelium from nasal scrapings and bronchial brushings.

Authors:  Nilceia Lopez-Souza; Pedro C Avila; Jonathan H Widdicombe
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jul-Aug       Impact factor: 2.416

2.  A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis.

Authors:  L E GIBSON; R E COOKE
Journal:  Pediatrics       Date:  1959-03       Impact factor: 7.124

3.  Airway Progenitor Clone Formation Is Enhanced by Y-27632-Dependent Changes in the Transcriptome.

Authors:  Susan D Reynolds; Cydney Rios; Agata Wesolowska-Andersen; Yongbin Zhuang; Mary Pinter; Carrie Happoldt; Cynthia L Hill; Scott W Lallier; Gregory P Cosgrove; George M Solomon; David P Nichols; Max A Seibold
Journal:  Am J Respir Cell Mol Biol       Date:  2016-09       Impact factor: 6.914

4.  Pharmacological Rescue of Conditionally Reprogrammed Cystic Fibrosis Bronchial Epithelial Cells.

Authors:  Martina Gentzsch; Susan E Boyles; Chaitra Cheluvaraju; Imron G Chaudhry; Nancy L Quinney; Crescentia Cho; Hong Dang; Xuefeng Liu; Richard Schlegel; Scott H Randell
Journal:  Am J Respir Cell Mol Biol       Date:  2017-05       Impact factor: 6.914

Review 5.  Cystic fibrosis genetics: from molecular understanding to clinical application.

Authors:  Garry R Cutting
Journal:  Nat Rev Genet       Date:  2014-11-18       Impact factor: 53.242

Review 6.  CFTR: folding, misfolding and correcting the ΔF508 conformational defect.

Authors:  Gergely L Lukacs; A S Verkman
Journal:  Trends Mol Med       Date:  2011-12-03       Impact factor: 11.951

7.  The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis.

Authors:  Michele D Bishop; Steven D Freedman; Julian Zielenski; Najma Ahmed; Annie Dupuis; Sheelagh Martin; Lynda Ellis; Julie Shea; Isobel Hopper; Mary Corey; Paul Kortan; Gregory Haber; Christine Ross; John Tzountzouris; Leslie Steele; Peter N Ray; Lap-Chee Tsui; Peter R Durie
Journal:  Hum Genet       Date:  2005-09-29       Impact factor: 4.132

8.  Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial.

Authors:  Felix Ratjen; Christopher Hug; Gautham Marigowda; Simon Tian; Xiaohong Huang; Sanja Stanojevic; Carlos E Milla; Paul D Robinson; David Waltz; Jane C Davies
Journal:  Lancet Respir Med       Date:  2017-06-09       Impact factor: 30.700

9.  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Authors:  Claire E Wainwright; J Stuart Elborn; Bonnie W Ramsey; Gautham Marigowda; Xiaohong Huang; Marco Cipolli; Carla Colombo; Jane C Davies; Kris De Boeck; Patrick A Flume; Michael W Konstan; Susanna A McColley; Karen McCoy; Edward F McKone; Anne Munck; Felix Ratjen; Steven M Rowe; David Waltz; Michael P Boyle
Journal:  N Engl J Med       Date:  2015-05-17       Impact factor: 91.245

Review 10.  Understanding Bland Altman analysis.

Authors:  Davide Giavarina
Journal:  Biochem Med (Zagreb)       Date:  2015-06-05       Impact factor: 2.313

View more
  29 in total

1.  In vitro 3D culture lung model from expanded primary cystic fibrosis human airway cells.

Authors:  Rachael E Rayner; Jack Wellmerling; Wissam Osman; Sean Honesty; Maria Alfaro; Mark E Peeples; Estelle Cormet-Boyaka
Journal:  J Cyst Fibros       Date:  2020-06-18       Impact factor: 5.482

2.  Molecular Dynamics and Theratyping in Airway and Gut Organoids Reveal R352Q-CFTR Conductance Defect.

Authors:  Sharon L Wong; Nikhil T Awatade; Miro A Astore; Katelin M Allan; Michael J Carnell; Iveta Slapetova; Po-Chia Chen; Jeffry Setiadi; Elvis Pandzic; Laura K Fawcett; John R Widger; Renee M Whan; Renate Griffith; Chee Y Ooi; Serdar Kuyucak; Adam Jaffe; Shafagh A Waters
Journal:  Am J Respir Cell Mol Biol       Date:  2022-07       Impact factor: 7.748

3.  Culture and Imaging of Human Nasal Epithelial Organoids.

Authors:  Zhongyu Liu; Justin D Anderson; Jennifer Natt; Jennifer S Guimbellot
Journal:  J Vis Exp       Date:  2021-12-17       Impact factor: 1.424

Review 4.  Established and novel human translational models to advance cystic fibrosis research, drug discovery, and optimize CFTR-targeting therapeutics.

Authors:  Deborah M Cholon; Martina Gentzsch
Journal:  Curr Opin Pharmacol       Date:  2022-04-21       Impact factor: 4.768

5.  Air-liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions.

Authors:  Domizia Baldassi; Bettina Gabold; Olivia Merkel
Journal:  Adv Nanobiomed Res       Date:  2021-05-06

Review 6.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

Review 7.  Nasal Epithelial Cell-Based Models for Individualized Study in Cystic Fibrosis.

Authors:  Duncan E Keegan; John J Brewington
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

8.  Rapid cystic fibrosis lung-function decline and in-vitro CFTR modulation.

Authors:  Emrah Gecili; Weiji Su; Cole Brokamp; Eleni-Rosalina Andrinopoulou; Francis J LaRosa Iii; Teresa Pestian; John P Clancy; George M Solomon; John J Brewington; Rhonda D Szczesniak
Journal:  J Cyst Fibros       Date:  2021-05-03       Impact factor: 5.527

9.  CFTR function and clinical response to modulators parallel nasal epithelial organoid swelling.

Authors:  Justin D Anderson; Zhongyu Liu; L Victoria Odom; Latona Kersh; Jennifer S Guimbellot
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-05-19       Impact factor: 6.011

10.  Personalized Medicine Based on Nasal Epithelial Cells: Comparative Studies with Rectal Biopsies and Intestinal Organoids.

Authors:  Iris A L Silva; Violeta Railean; Aires Duarte; Margarida D Amaral
Journal:  J Pers Med       Date:  2021-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.